Table 2.
Characteristics of patients based on telehealth visits, Jan–Oct 2019 and 2020.
| 2019 (n = 1,775) | 2020 (n = 43,997) | Total (n = 45,772)a | |
|---|---|---|---|
| Age at visit, years, mean (SD) | 31.2 (11.7) | 11.0 (8.1) | 11.8 (9.3) |
| Sex, n(%) | |||
| Female | 1,353 (76.2) | 21,200 (48.2) | 22,553 (49.3) |
| Male | 422 (23.8) | 22,790 (51.8) | 23,212 (50.7) |
| Unknown | 0 (0) | 7 (0.02) | 7 (0.02) |
| Race/ethnicity, n(%) | |||
| Non-Hispanic white | 158 (8.9) | 14,859 (33.8) | 15,017 (32.8) |
| Non-Hispanic black | 31 (1.8) | 8,703 (19.8) | 8,734 (19.1) |
| Hispanic | 83 (4.7) | 14,456 (32.9) | 14,539 (31.8) |
| Other/unknown | 1,503 (84.7) | 5,979 (13.6) | 7,482 (16.4) |
| Parent preferred language, n(%) | |||
| English | 333 (18.8) | 35,977 (81.8) | 36,310 (79.3) |
| Spanish | 5 (0.3) | 5,543 (12.6) | 5,548 (12.1) |
| Other | 1,437 (81.0) | 2,477 (5.6) | 3,914 (8.6) |
| State, n(%) | |||
| Texas | 1,761 (99.2) | 43,341 (98.5) | 45,102 (98.5) |
| Other | 14 (0.8) | 656 (1.5) | 670 (1.5) |
| Insurance, n(%) | |||
| Government | 1 (0) | 25,066 (56.9) | 25,067 (54.8) |
| Commercial | 1,769 (99.7) | 18,584 (42.2) | 20,353 (44.5) |
| Self-pay/unknown | 5 (0.3) | 347 (0.8) | 352 (0.8) |
| Primary diagnosis, n(%) | |||
| Infectious disease | N/Ab | 322 (0.7) | 322 (0.7) |
| Neoplasms | 339 (0.8) | 339 (0.8) | |
| Diseases of the blood and blood-forming organs | 695 (1.6) | 695 (1.5) | |
| Endocrine, nutritional, and metabolic disease | 6,776 (15.4) | 6,776 (14.8) | |
| Mental and neurodevelopmental disorders | 9,782 (22.2) | 9,782 (21.4) | |
| Disease of eye and ear | 1,173 (2.7) | 1,173 (2.6) | |
| Circulatory system disease | 1,049 (2.4) | 1,049 (2.3) | |
| Respiratory system disease | 4,070 (9.3) | 4,070 (8.9) | |
| Digestive system disease | 4,415 (9.6) | 4,415(9.6) | |
aThe total visits in this table do not include telehealth urgent care patient visits from 2019 and 2020.
bThe primary diagnosis for telehealth visits in 2019 is not available in the electronic health record.